Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

35 results about "Use insulin" patented technology

Glucose-sensitive insulin derivatives

To provide glucose-sensitive insulin derivatives having a prolonged half life that allows for less frequent administration.SOLUTION: The invention relates to a novel insulin derivative and their uses in the treatment or prevention of medical conditions relating to diabetes. The insulin derivative is glucose-sensitive, and exhibits glucose-sensitive albumin binding. The insulin derivative has a long half-life. The invention also relates to novel intermediates. Finally, the invention provides a pharmaceutical composition comprising the insulin derivative of the invention, and the use of such a composition in the treatment or prevention of medical conditions relating to diabetes.SELECTED DRAWING: None
Owner:NOVO NORDISK AS

Method and system for automatic monitoring of diabetes related treatments based on insulin injections

Some embodiments relate to a method and system for automatic monitoring of diabetes related treatments based on insulin injections. The technique enables to receive at least raw log glucose data and provide a recommended patient-specific insulin injections treatment plan (i.e. automatic individualized recommendations to change insulin therapy) to patients on insulin, either on long acting insulin only or on Multiple Daily Injections (i.e. MDI treatment), based on the data analysis.
Owner:DREAMED DIABETES

Continuous dynamic blood glucose monitoring management method in intensive care unit

The invention discloses a continuous dynamic blood glucose monitoring management method in an intensive care unit, which relates to the technical field of data analysis and processing, and comprises the following steps: collecting blood glucose data of a patient in real time, and setting blood glucose correction frequency based on the blood glucose data; calculating the dose of insulin used by the patient based on the corrected and collected blood glucose data; determining a blood glucose fluctuation range in the patient based on the blood glucose fluctuation adjustment value, determining a blood glucose level range according to the blood glucose value of the patient, and formulating a patient treatment scheme; displaying blood glucose monitoring and insulin treatment data in real time, and generating a patient data report; and establishing a remote cooperation platform, and carrying out data sharing and real-time communication cooperation. According to the method, the blood glucose data of the patient is detected through the continuous dynamic blood glucose detector, the pain of the patient is relieved, medical workers do not need to inject insulin manually through automatic insulin infusion, the working efficiency and the treatment experience of the patient are improved, and the medical workers are helped to master the blood glucose condition of the patient through a whole-process monitoring display interface.
Owner:FUDAN UNIV SHANGHAI CANCER CENT

Insulin pen for patients with visual impairment

The insulin pen for the visual impairment patient comprises a refill frame and an auxiliary positioning mechanism, a pen body is fixedly connected to the surface of the top of the refill frame, an adjusting knob is installed on the surface of the top of the pen body, and the auxiliary positioning mechanism is arranged on the surface of the outer side of the refill frame. An auxiliary metering mechanism is arranged on the surface of the outer side of the pen body, convenience and accuracy are provided for a patient with visual impairment to use the insulin pen, the patient can easily find the injection position by using the soft plug to position the abdomen position as the benchmark and positioning the positioning hole in the paperboard, and the accuracy of the insulin pen is improved. The design of the rotating guide rail and the sliding insertion groove enables the refill frame to accurately move on the positioning paperboard and align to the injection position, the injection precision and accuracy are improved, the stability and safety of the rotating angle are guaranteed through the arrangement of the limiting block and the screwing bolt, and excessive rotation or accidental movement is avoided.
Owner:JINGJIANG PEOPLES HOSPITAL

Methods of using and compositions including an incretin analog

Doses and dosing regimens for incretin analogs are disclosed comprising determining and administering doses of long-acting incretin analogs suitable for once-weekly dosing, such as a glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon (GCG) (GGG) tri-receptor agonist.
Owner:ELI LILLY & CO

Insulin management for insulin delivery during fasting periods

A method of insulin management implemented by an insulin delivery system comprising an insulin delivery device (130) is provided. The method comprises: detecting (201) an activation activity associated with a preparation for using an insulin delivery device (130) in the form of an automatic insulin delivery device attachable to the body of the user over the duration of a fasting period over the entire time period; and initiating (202) an automatic delivery of insulin in the form of a corrected bolus dose in response to the periodically received blood glucose measurements during the fasting period.
Owner:LUNA HEALTH INC

Methods of using and compositions including an incretin analog

Doses and dosing regimens for incretin analogs are disclosed comprising determining and administering doses of long-acting incretin analogs suitable for once-weekly dosing, such as a glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon (GCG) (GGG) tri-receptor agonist.
Owner:ELI LILLY & CO

Insulin injection assist device

The utility model provides an insulin injection assisting device which comprises a holding shaft and at least two positioners with different colors, each positioner comprises an inner edge part, an outer edge part, a first side edge part and a second side edge part, and the inner edge part, the first side edge part, the outer edge part and the second side edge part are sequentially connected and define an injection area; the at least two positioners are arranged around the axis of the object holding shaft and are spliced with each other, the inner edge parts of the positioners are clamped on the outer side wall of the object holding shaft, and the object holding device has a series of advantages of convenience in use, high operation reliability, simple structure, easiness in operation and the like; the insulin injection device is very suitable for the old and other patients who have poor identification ability and use insulin injection for the first time.
Owner:SHANGHAI GERIATRIC MEDICINE CENT

Adjusting insulin delivery rates

A method may include delivering insulin, using an insulin pump and a controller, over a first diurnal time period based on a baseline basal insulin rate stored in memory. The controller may receive blood glucose data to control delivery of insulin via the insulin pump in amounts variable from the baseline basal insulin rate to control blood glucose levels for a person with diabetes (PWD). The method may also include modifying the baseline basal insulin rate stored in the memory for a second diurnal time period that is at least 20 hours after the first diurnal period based on an amount of insulin actually delivered during the first diurnal time period.
Owner:INSULET CORP

Counting type insulin needle recovery device

The utility model discloses a counting type insulin needle recycling device which comprises a shell, the interior of the shell is a cavity, a partition plate is arranged in the shell and divides the interior of the shell into a storage chamber and a recycling chamber, drawers capable of being pulled out are evenly distributed on one side of the storage chamber in the height direction of the shell, and the recycling chamber is communicated with the storage chamber. A plurality of fixing plugs used for containing insulin needles are arranged at the bottom of the drawer, a round hole is formed in the upper end of the recycling chamber, a supporting plate is arranged below the round hole and located in the recycling chamber, first electric push rods are symmetrically arranged on the two sides of the round hole, and the telescopic ends of the first electric push rods are connected with L-shaped plates; according to the counting type insulin needle recycling device, used insulin needles can be collected, the number of the used insulin needles can be checked at any time, the insulin needles are prevented from being lost, and the use safety and convenience are improved.
Owner:HANGZHOU XIXI HOSPITAL

Refrigerated cup

1. The name of the product of this design: Refrigerated cup. 2. Purpose of this design product: used for insulin refrigerated cup. 3. The design key point of this appearance design product lies in the shape. 4. The picture or photo that best illustrates the design points: Stereoscopic diagram 1.
Owner:NINGBO KAIJI BEAR ELECTRICAL APPLIANCE CO LTD

Use of inhibitors of insulin-like growth factor receptor-1 for rheumatoid arthritis

Provided are methods of treating rheumatoid arthritis comprising administering one or more compounds that inhibit insulin-like growth factor receptor- 1 (IGF-1R). Specifically, the disclosure provides a method for treating a subject having rheumatoid arthritis, comprising administering to the subject, in need thereof, a therapeutically effective amount of one or more compounds that inhibits IGF-1R. Further disclosed are IGF-1R inhibitor compounds used for the method.
Owner:SLING THERAPEUTICS INC +5

Materials and methods of using proinsulin mRNA nanoparticles

The disclosure provides a method of inducing immune tolerance to beta cells in a subject in need thereof. The method comprises administering to the subject a composition comprising a nanoparticle comprising a positively-charged surface and an interior comprising (i) a core and (ii) at least two mRNA layers, wherein each mRNA layer is positioned between a cationic lipid bilayer, and the mRNA encodes a proinsulin peptide. The disclosure also provides a method of treating or delaying the onset of Type 1 diabetes in a subject in need thereof, the method comprising administering to the subject a composition comprising a nanoparticle comprising a positively-charged surface and an interior comprising (i) a core and (ii) at least two mRNA layers, wherein each mRNA layer is positioned between a cationic lipid bilayer, and the mRNA encodes a proinsulin peptide.
Owner:UNIV OF FLORIDA RESEARCH FOUNDATION INC

Insulin analogs

The present invention relates to insulin analogs, particularly insulin analogs having shortened B chains. The present invention also relates to the crystal structure of insulin from the venom of cone snails and to methods of using the crystal and related structural information to screen for and design insulin analogs that interact with or modulate the insulin receptor. The present invention also relates to therapeutic and prophylactic methods using insulin analogs.
Owner:THE WALTER AND ELIZA HALL INSTITUTE OF MEDECAL RESEARCH +1

Combination therapy for PI3k-associated disease or disorder

Described herein are compositions and methods for treating a disease or disorder associated with PI3K signaling. For example, such compositions can include use of modulators of glucose metabolism, use of at least one kinase in the insulin-receptor / PI3K / AKT / mTOR pathway, and / or use of diet that influences the subject's metabolic state.
Owner:CORNELL UNIVERSITY +1

Insulin pen injection needle capable of preventing needle stick injury

The utility model belongs to the technical field of medical injection instruments, and particularly relates to an insulin pen injection needle capable of preventing needle stick injury, which comprises an insulin pen main body, and the end part of the insulin pen main body is connected with a needle instrument; the insulin pen further comprises a supporting cylinder, the insulin pen body is fixedly installed in the supporting cylinder, a telescopic cylinder is arranged at the opening of the end of the supporting cylinder in a telescopic mode through an elastic piece, the telescopic cylinder is used for protecting the needling instrument, and when the insulin pen body is not used, the needling instrument retracts into the telescopic cylinder under the supporting effect of the elastic piece; the protection effect on the insulin pen main body is achieved; a contact ring is detachably installed at the end of the telescopic cylinder, and when insulin injection is conducted, through the arranged contact ring, friction contact force exists between the contact ring and the skin of a patient, and pre-positioning can be conducted during insulin injection.
Owner:903 HOSPITAL OF THE JOINT LOGISTICS SUPPORT FORCE OF THE PEOPLES LIBERATION ARMY OF CHINA

Fixing plaster for insulin pump

The utility model provides a fixed application for an insulin pump, which relates to the technical field of medical instruments, and comprises an application, the application is used for fixing an infusion needle of the insulin pump, the infusion needle penetrates through the middle position in the application, one side of the infusion needle is connected with an infusion catheter, and the other side of the infusion needle is connected with an infusion tube. A fastening adhesive tape is arranged on the outer surface of the infusion catheter, and the fastening adhesive tape is used for fixing the infusion catheter; through the arrangement of the application and the fastening adhesive tape, the infusion needle head can be firmly fixed in the insulin pump, the fixing effect and the wearing comfort of the insulin pump are effectively improved, adverse effects of skin are reduced, and a better guarantee is provided for a patient to use the insulin pump.
Owner:季晓

Multifunctional insulin pen

The utility model relates to the technical field and discloses a multifunctional insulin pen. The multifunctional insulin pen comprises a driving tube, a pushing rod, a core sleeve, a needle head and a protective sleeve. A driving assembly is arranged in the driving pipe, and the driving pipe is movably connected with the pushing rod through the driving assembly; the pushing rod comprises an outer pushing pipe and an inner pushing rod; the inner push rod is movably connected with the outer push tube, the core sleeve is detachably connected with the outer push tube, one end of the inner push rod is located in the core sleeve, the other end of the core sleeve is detachably connected with the needle head, and the protective sleeve is detachably connected with the needle head. Guiding can be provided when a patient uses insulin, automatic injection can be achieved, and the injection time efficiency is fully guaranteed.
Owner:SHANGHAI FIRST PEOPLES HOSPITAL

Genotype stratification in diabetes treatment and prevention

To provide an insulin autoantigen for use in immunotherapy for treatment or prevention of autoimmune diabetes in an individual.SOLUTION: The present invention relates to an insulin autoantigen for use in immunotherapy including: determining the HLA haplotype of an individual; and subjecting the individual to a treatment regimen based on the haplotype. An individual having any of (i) to (iii) in the following is subjected to the treatment using at least the insulin autoantigen: (i) an individual having a DR4-DQ8 haplotype and not having a DR3-DQ2 haplotype; (ii) an individual having an HLA DR3 / 4-DQ2 / 8 genotype; and (iii) an individual having an HLA-DR4 / 4-DQ8 / 8 haplotype.SELECTED DRAWING: None
Owner:DIAMYD MEDICAL

Insulin pen with use assisting function

The utility model provides an insulin pen with an auxiliary use function, and belongs to the technical field of insulin pens. The problems that in the prior art, a function of assisting patients in use is not achieved, and the effective time of insulin cannot be monitored are solved. The insulin aging monitoring pen comprises a pen holder and a pen cap, a monitoring device used for monitoring insulin aging is arranged on the pen holder, a using auxiliary device is arranged on the pen cap, and the using auxiliary device comprises a mounting column, a voice broadcaster and a control switch, and the voice broadcaster and the control switch are arranged on the mounting column. The insulin pen has the advantages of being capable of effectively assisting a patient in using the insulin pen and monitoring the service life of insulin and the like.
Owner:HANGZHOU YUHANG DISTRICT NO 5 PEOPLES HOSPITAL

Combinations of IRS / STAT3 dual modulators and anti-cancer agents for treating cancer

Provided is a treatment of cancer using a dual modulator of Insulin Receptor Substrate (IRS) and signal transducer and activator of transcription 3 (Stat3), as well with other agents. The combination can be used to treat a tumor that has developed resistance to an EGFR inhibitor, EGFR antibody, mTOR inhibitor, MEK inhibitor, mutated B-Raf inhibitor, chemotherapeutic agents, and certain combinations thereof, or to prevent acquired resistance of a tumor to any of said inhibitors or agents, or to prevent tumor recurrence following cease of treatment with any of said inhibitors or agents or a combination thereof. The subject matter further provides a treatment of cancer using combination therapy comprising a dual modulator of IRS and Stat3, in combination with an immunotherapy agent. The combination can be used to sensitize a tumor to immunotherapy.
Owner:TYRNOVO LTD

Preparation method and application of dark brown boletus polysaccharide

PendingCN122277763ACelluloseCell membrane
This invention belongs to the field of fungal polysaccharide application technology, specifically relating to a method for preparing and applying polysaccharide from *Boletus globosum*. Crude polysaccharide was extracted from the fruiting body of *Boletus globosum* using hot water extraction, and purified using DEAE-52 cellulose column chromatography. Subsequently, by establishing an alcohol-induced liver injury model, it was found that NOP-1 significantly reduced ALT and AST levels, while simultaneously decreasing MDA content and increasing SOD activity and GSH levels, indicating that NOP-1 can inhibit lipid peroxidation, enhance the antioxidant defense capacity of hepatocytes, and maintain hepatocyte membrane integrity. A HepG2 cell IR model was constructed using a high-glucose, high-insulin combined induction method, determining the optimal dosage of NOP-1. ‑6 Treatment of HepG2 cells with mol / L insulin for 24 h successfully induced insulin resistance. Glucose consumption experiments in IR HepG2 cells demonstrated that NOP-1 significantly enhanced the glucose consumption capacity of insulin-resistant cells, exhibiting significant in vitro hypoglycemic activity.
Owner:HAINAN NORMAL UNIV

Prediction based delivering or guiding of therapy for diabetes

An example system for therapy delivery includes one or more processors configured to in response to a prediction indicating that the meal event is to occur, output instructions to an insulin delivery device to deliver a partial therapy dosage, to a device to notify the patient to use the insulin delivery device to take the partial therapy dosage, or to the insulin delivery device to prepare the partial therapy dosage prior to the meal event occurring, and in response to a determination indicating that the meal event is occurring (e.g., based on movement characteristics of a patient arm), output instructions to the insulin delivery device to deliver a remaining therapy dosage, to the device to notify the patient to use the insulin delivery device to take the remaining therapy dosage, or to the insulin delivery device to prepare the remaining therapy dosage.
Owner:MEDTRONIC MINIMED INC

Automatic insulin auxiliary use device and application method thereof

The invention relates to the field of medical instruments, in particular to an automatic insulin use assisting device and an application method thereof.The automatic insulin use assisting device comprises a control cylinder, an insulin pushing assembly is connected to the interior of the control cylinder, and an insulin pen fixing assembly is connected to the outer side of the lower end of the control cylinder and used for fixing an insulin pen; an exhaust monitoring assembly is connected to the outer sides of the control cylinder and the insulin pen fixing assembly. The insulin dosage can be automatically set, and the problem that patients with visual impairment and old people are difficult to accurately set the dosage is solved; due to the automatic exhaust function, the insulin injection accuracy is guaranteed, and injection errors caused by air residues are reduced; the voice broadcast function is convenient for old people and patients with visual impairment to use the insulin pen; the function associated with the mobile phone enables family members to know the insulin use condition of the patient in real time; through the detachable and recyclable design of the device arranged in the scheme, the economic burden of the patient is relieved.
Owner:ZHEJIANG UNIV

Insulin premix formulation and product, methods of preparing the same, and methods of using the same

To provide a single-use, sterile, stable and ready-to-use insulin premix product.SOLUTION: The present invention provides a pharmaceutically acceptable insulin premix formulation that contains i) about 0.1-10.0 Unit / mL of insulin based on the total formulation and ii) water. The insulin premix formulation has a pH value of about 6.5 to about 7.2.SELECTED DRAWING: Figure 3
Owner:BAXTER INT INC +1

Methods of using and compositions including an incretin analog

Doses and dosing regimens for incretin analogs are disclosed comprising determining and administering doses of long-acting incretin analogs suitable for once-weekly dosing, such as a glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon (GCG) (GGG) tri-receptor agonist.
Owner:ELI LILLY & CO

Biopharmaceutical formulations including polymer excipients

The present disclosure provides compositions including a polyacrylamide-based copolymer, one or more preservatives, and insulin or an analog thereof. Also provided are methods of using the insulin compositions, including methods of administering the compositions to a human subject in need thereof.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV